Coronavirus Spike Glycoprotein (CoV S) Peptide
CoV S
Reactivity: Middle East Respiratory Syndrome Coronavirus (MERS-CoV), SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
Host: Synthetic
InhA
3 images
(3 references)
Catalog No. ABIN6952488
Shipping to:
United States
Contact our Customer Service for availability and price in your country.
Contact Info
Quick Overview for Coronavirus Spike Glycoprotein (CoV S) Peptide (ABIN6952488)
Target
Coronavirus Spike Glycoprotein (CoV S)
Origin
Middle East Respiratory Syndrome Coronavirus (MERS-CoV), SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2)
Source
Synthetic
Application
Inhibition Assay (InhA)
-
-
Sequence
- SLDQINVTFL DLEYEMKKLE EAIKKLEESY IDLKEL
-
Characteristics
- EK1 / Pan-HCoV S Inhibitor
-
Purity
- ≥ 95 %
-
Components
- Each vial contains 100 μg of NET peptide.
-
-
Coronavirus Spike Glycoprotein (CoV S) peptide (Cy5)
CoV S Reactivity: Middle East Respiratory Syndrome Coronavirus (MERS-CoV), SARS Coronavirus (SARS-CoV), SARS Coronavirus-2 (SARS-CoV-2) Host: Synthetic InhA
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Powder
-
Storage
- RT,4 °C,-20 °C
-
Storage Comment
- Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
-
-
-
: "Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein." in: Cellular & molecular immunology, (2020) (PubMed).
: "Drug treatment options for the 2019-new coronavirus (2019-nCoV)." in: Bioscience trends, Vol. 14, Issue 1, pp. 69-71, (2020) (PubMed).
: "A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike." in: Science advances, Vol. 5, Issue 4, pp. eaav4580, (2019) (PubMed).
-
: "Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein." in: Cellular & molecular immunology, (2020) (PubMed).
-
- Coronavirus Spike Glycoprotein (CoV S)
-
Target Type
- Viral Protein
-
Molecular Weight
- 4332
Target
-
You are here:
